{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:05:19Z","timestamp":1719187519441},"reference-count":48,"publisher":"Informa UK Limited","issue":"29","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.2217\/fon-2017-0211","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T14:06:05Z","timestamp":1508162765000},"page":"2645-2665","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy"],"prefix":"10.1080","volume":"13","author":[{"given":"Shweta","family":"Lawania","sequence":"first","affiliation":[{"name":"Department of Biotechnology,Thapar University,\rPatiala,\rPunjab 147002,\rIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine,Post Graduate Institute of Medical Education & Research (PGIMER),\rSector 14,\rChandigarh,\rIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digamber","family":"Behera","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine,Post Graduate Institute of Medical Education & Research (PGIMER),\rSector 14,\rChandigarh,\rIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology,Thapar University,\rPatiala,\rPunjab 147002,\rIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"e_1_3_4_3_1","first-page":"5612","article-title":"A variant within the DNA repair gene XRCC3 is associated with the development of melanoma","volume":"60","author":"Winsey S","year":"2010","unstructured":"Winsey S , HaldarNA, MarshHP, BunceM, MarshallSE, HarrisAL. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma. Cancer Res.60, 5612\u20135616 (2010).","journal-title":"Cancer Res."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.032"},{"key":"e_1_3_4_5_1","first-page":"262","article-title":"Medical genetics","volume":"1","author":"Chen Z","year":"2001","unstructured":"Chen Z . Medical genetics. People Hygienic Press Beijing1, 262\u2013263 (2001).","journal-title":"People Hygienic Press Beijing"},{"key":"e_1_3_4_6_1","first-page":"1513","article-title":"Polymorphisms in DNA repair gene and associations with cancer risk","volume":"11","author":"Goode EL","year":"2002","unstructured":"Goode EL , UlrichCM, PotterJD. Polymorphisms in DNA repair gene and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev.11, 1513\u20131530 (2002).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(96)90006-4"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/17.6.463"},{"key":"e_1_3_4_9_1","first-page":"604","article-title":"Non conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen MR","year":"1998","unstructured":"Shen MR , JonesIM, MohrenweiserH. Non conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res.58, 604\u20138 (1998).","journal-title":"Cancer Res."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.12.2219"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.3.403"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.6.899"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.4.593"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1228"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7010.899"},{"key":"e_1_3_4_16_1","first-page":"376","volume-title":"Cancer: Principles and Practice of Oncology (6th Edition).","author":"Johnson SW","year":"2001","unstructured":"Johnson SW , StevensonJP, O\u2019DwyerPJ, DeVitaVT, HellmanS, RosenbergSA. Cisplatin and its analogues. In: Cancer: Principles and Practice of Oncology (6th Edition).DevitaVT, HellmanS, RosenbergSA (Eds). Lipincott Williams & Wilkins, PA, USA376\u2013388 (2001)."},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.14.1091"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.143"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.12.026"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(02)00184-8"},{"key":"e_1_3_4_21_1","first-page":"1377","article-title":"Gene\u2013environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer","volume":"62","author":"Zhou W","year":"2002","unstructured":"Zhou W , LiuG, MillerDPet al. Gene\u2013environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res.62, 1377\u20131381 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2005.06.021"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11136"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00638-9"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi232"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.2.295"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004764200"},{"key":"e_1_3_4_28_1","first-page":"1354","article-title":"Modulation of nucleotide excision capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz MR","year":"2001","unstructured":"Spitz MR , WuX, WangYet al. Modulation of nucleotide excision capacity by XPD polymorphisms in lung cancer patients. Cancer Res.61, 1354\u20137 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-162"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.01.027"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.4.599"},{"key":"e_1_3_4_32_1","first-page":"2","article-title":"Genetic polymorphism of DNA repair gene ERCC2\/XPD (Arg156Arg) (A22541C) and lung cancer risk in Northern Romania","volume":"20","author":"Catana A","year":"2012","unstructured":"Catana A , PoppAR, PopM, PorojanMD, PetrisorFM, PopIV. Genetic polymorphism of DNA repair gene ERCC2\/XPD (Arg156Arg) (A22541C) and lung cancer risk in Northern Romania. RevistaRomana de Medicina de Laborator20, 2\u20134 (2012).","journal-title":"RevistaRomana de Medicina de Laborator"},{"key":"e_1_3_4_33_1","first-page":"77","article-title":"Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma","volume":"8","author":"Dybdahl M","year":"1999","unstructured":"Dybdahl M , VogelU, FrentzG, WallinH, NexoBA. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomark. Prev.8, 77\u201381 (1999).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"e_1_3_4_34_1","first-page":"355","article-title":"Associations between ercc2 polymorphisms and gliomas","volume":"10","author":"Caggana M","year":"2001","unstructured":"Caggana M , KilgallenJ, ConroyJMet al. Associations between ercc2 polymorphisms and gliomas. Cancer Epidemiol. Biomark. Prev.10, 355\u2013360 (2001).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12073"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm167"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-1985-9"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.11.004"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2013.14.1.145"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182307e1f"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256406"},{"key":"e_1_3_4_42_1","first-page":"859","article-title":"Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers","volume":"10","author":"Yao CY","year":"2009","unstructured":"Yao CY , HuangXE, LiCet al. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers. Asian Pac. J. Cancer Prev.10, 859\u2013864 (2009).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.6.2583"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3181b9cedc"},{"key":"e_1_3_4_45_1","article-title":"Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients","volume":"7","author":"Wu W","year":"2012","unstructured":"Wu W , LiH, WangHet al. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients. PLoS ONE7, e33200 (2012).","journal-title":"PLoS ONE"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262744"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603079"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1556-0864(15)31629-4"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0720-3"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1632-x"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2017-0211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:26Z","timestamp":1719125066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2017-0211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":48,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.2217\/fon-2017-0211"],"URL":"https:\/\/doi.org\/10.2217\/fon-2017-0211","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}